Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?


    loading  Checking for direct PDF access through Ovid

Abstract

Linked Article:Stranzenbach et al. Br J Dermatol 2017; 177:1503–1509.

    loading  Loading Related Articles